Literature DB >> 16420399

Aging and oxidative stress in progressive supranuclear palsy.

K Aoyama1, K Matsubara, S Kobayashi.   

Abstract

Progressive supranuclear palsy (PSP) is a neurodegenerative disorder, which may possibly be induced by oxidative stress. However, the age-related alteration of the endogenous antioxidant system is not well understood. To better understand this, we measured Cu/Zn-superoxide dismutase (SOD), glutathione peroxidase (GPx), and 4-hydroxynonenal (HNE)-conjugated GPx in cerebrospinal fluid of PSP patients by enzyme linked immunosorbent assay. A significant increase in the Cu/Zn-SOD level was detected in PSP group compared with controls. The levels of Cu/Zn-SOD and GPx in PSP group showed positive correlations with age. Two-thirds of total GPx was present as the HNE-conjugated form with positive correlation in PSP group. In conclusion, the endogenous antioxidant system of PSP patients appears to be activated with aging, however, it might be unable to function effectively because of conjugation with HNE.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16420399     DOI: 10.1111/j.1468-1331.2006.01139.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  12 in total

Review 1.  4-Hydroxy-nonenal-A Bioactive Lipid Peroxidation Product.

Authors:  Rudolf J Schaur; Werner Siems; Nikolaus Bresgen; Peter M Eckl
Journal:  Biomolecules       Date:  2015-09-30

2.  Improvement of balance after audio-biofeedback. A 6-week intervention study in patients with progressive supranuclear palsy.

Authors:  S Nicolai; A Mirelman; T Herman; A Zijlstra; M Mancini; C Becker; U Lindemann; D Berg; W Maetzler
Journal:  Z Gerontol Geriatr       Date:  2010-08       Impact factor: 1.281

3.  Relationship between uric acid levels and progressive supranuclear palsy.

Authors:  David M Brody; Irene Litvan; Steve Warner; David E Riley; Deborah A Hall; Benzi M Kluger; David R Shprecher; Christopher R Cunningham
Journal:  Mov Disord       Date:  2016-02-18       Impact factor: 10.338

4.  LX2343 alleviates cognitive impairments in AD model rats by inhibiting oxidative stress-induced neuronal apoptosis and tauopathy.

Authors:  Xiao-Dan Guo; Guang-Long Sun; Ting-Ting Zhou; Yi-Yang Wang; Xin Xu; Xiao-Fan Shi; Zhi-Yuan Zhu; Vatcharin Rukachaisirikul; Li-Hong Hu; Xu Shen
Journal:  Acta Pharmacol Sin       Date:  2017-06-26       Impact factor: 6.150

Review 5.  Mitochondrial medicine for neurodegenerative diseases.

Authors:  Heng Du; Shirley ShiDu Yan
Journal:  Int J Biochem Cell Biol       Date:  2010-01-11       Impact factor: 5.085

6.  Protein Phosphatase 2A and Its Methylation Modulating Enzymes LCMT-1 and PME-1 Are Dysregulated in Tauopathies of Progressive Supranuclear Palsy and Alzheimer Disease.

Authors:  Hye-Jin Park; Kang-Woo Lee; Stephanie Oh; Run Yan; Jie Zhang; Thomas G Beach; Charles H Adler; Michael Voronkov; Steven P Braithwaite; Jeffry B Stock; M Maral Mouradian
Journal:  J Neuropathol Exp Neurol       Date:  2018-02-01       Impact factor: 3.685

Review 7.  Tau Hyperphosphorylation and Oxidative Stress, a Critical Vicious Circle in Neurodegenerative Tauopathies?

Authors:  Seyedeh Maryam Alavi Naini; Nadia Soussi-Yanicostas
Journal:  Oxid Med Cell Longev       Date:  2015-10-20       Impact factor: 6.543

8.  Immunohistochemical Study of Mitochondrial Ferritin in the Midbrain of Patients with Progressive Supranuclear Palsy.

Authors:  Zulzikry Hafiz Abu Bakar; Tomoko Kato; Daijiro Yanagisawa; Jean-Pierre Bellier; Ken-Ichi Mukaisho; Ikuo Tooyama
Journal:  Acta Histochem Cytochem       Date:  2021-06-23       Impact factor: 1.938

Review 9.  Impaired glutathione synthesis in neurodegeneration.

Authors:  Koji Aoyama; Toshio Nakaki
Journal:  Int J Mol Sci       Date:  2013-10-18       Impact factor: 5.923

10.  RT001 in Progressive Supranuclear Palsy-Clinical and In-Vitro Observations.

Authors:  Plamena R Angelova; Kristin M Andruska; Mark G Midei; Mario Barilani; Paldeep Atwal; Oliver Tucher; Peter Milner; Frederic Heerinckx; Mikhail S Shchepinov
Journal:  Antioxidants (Basel)       Date:  2021-06-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.